Raportul
Știri verificate despre finanțări, sedii centrale și leadership de la cele mai inovatoare companii din lume
66 rapoarte și mai multe
Sava Raises $10M Seed Round Led by Gradient Ventures
Sava emerged from stealth with a $10 million seed round led by Gradient Ventures and launched Sava Trust Company, a Nevada-chartered trust company.
Omnichat Raises US$10M Series A for Agentic Customer Experience Platform
Omnichat raised a US$10 million Series A led by Openspace Capital to scale its agentic AI platform, deepen R&D on Omni AI Agents and expand globally.
OMass Therapeutics Raises $310M Series C for Small-Molecule Therapeutics
OMass Therapeutics raised an oversubscribed $310 million Series C co-led by Bain Capital Life Sciences, Forbion and Novo Holdings to advance its small molecule pipeline in endocrinology and immunology.
Jeeves Raises $110M Equity Round for Stablecoin-Native Banking
Jeeves raised a $110 million equity round led by CoinFund to scale its stablecoin-native banking platform for global enterprises across 35 countries.
Nix Biosensors Raises $10M Series A for Hydration Intelligence
Nix Biosensors closed a $10 million Series A to develop Nix Health and bring personalized hydration data into consumer-health platforms.
Diameter Pay Raises $10M Series A for Global US Dollar Payments
Diameter Pay raised a $10 million Series A co-led by CMT Digital and Lightspeed Faction to expand its U.S. dollar payments and virtual accounts platform for banks and fintechs.
Velaura AI Raises $110M Series A for Ultra-Low-Power AI Silicon
Velaura AI raised a $110 million Series A led by Seligman Ventures to accelerate its ultra-low-power AI compute silicon and software, bringing its valuation to more than $1 billion.
Malachyte Raises $10M Seed for E-Commerce Behavior Intelligence
Malachyte raised a $10 million seed round co-led by Bessemer Venture Partners and Gradient Ventures to scale distribution and hire senior commercial and product leadership.
Wellinks Announces $10M First Close of Series B Funding
Wellinks announced the first close of a $10 million Series B with participation from UMass Memorial Health and inside investors to fund commercial growth in cardiopulmonary care.
Afișare 9 rapoarte • Pagina 1 • Categorie: all
Rămâneți înaintea pieței
Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.